
#42 - Nicole K. Paulk, CEO & Founder at Siren Biotechnology
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
-
Narrated by:
-
By:
About this listen
Join us on the latest episode! Our Guest: Nicole K. Paulk, CEO & Founder at Siren Biotechnology.
What you'll get out of this episode:
- Nicole Paulk's early inspiration in gene therapy during her PhD at OHSU.
- The transition from academia to entrepreneurship amid COVID-19.
- Siren Biotechnology's innovative approach with AAV immunogene therapy.
- The challenges and successes in securing funding and navigating regulatory landscapes.
- The exciting transition of Siren Biotechnology from preclinical to clinical trials.
To Learn More About Our Guest And Their Company:
LinkedIn https://www.linkedin.com/in/nicolepaulk/
Company LinkedIn https://www.linkedin.com/company/siren-biotechnology-inc/
Website https://sirenbiotechnology.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet